# Major Recall Alert: PMS-SUMATRIPTAN Recalled Due to Incorrect Tablet Count in Blister Packs
Health Canada has issued an important recall notice for PMS-SUMATRIPTAN. The affected lots of this medication may not contain the correct number of tablets, with reports of empty blister packs being discovered. If you use this product, this recall is essential for your safety and health. Here’s everything you need to know.
## Why This Recall is Important
PMS-SUMATRIPTAN is a common medication used to treat migraines by narrowing blood vessels and reducing the chemicals in the body that trigger migraine symptoms. For patients who depend on this drug, inconsistencies in the number of tablets can present significant health risks, ranging from delayed treatment to potential misuse.
Empty blister packs in affected lots could lead to:
- Missed doses for individuals needing immediate relief.
- Potential problems for those relying on this medication as part of a treatment plan.
- Reduced trust in the integrity of the product’s packaging and supply chain.
By addressing this issue, health authorities and manufacturers want to ensure that patients receive safe and effective products.
## Details of the Recall
The recall includes specific lots of PMS-SUMATRIPTAN. If you have this product at home, take note of the following details:
- **Brand**: PMS-SUMATRIPTAN
- **Product Class**: Migraine Relief Medication
- **Reason for Recall**: Some blister packs in the affected lots may not contain the correct amount of tablets, with instances of empty blister packs reported.
- **Date of Announcement**: October 25, 2023
You can find Health Canada’s official announcement and updates on the recall [here](https://recalls-rappels.canada.ca/en/alert-recall/pms-sumatriptan-may-not-contain-correct-amount-tablets-empty-blister-packs).
## What You Should Do
To protect yourself and your loved ones, it’s critical to act immediately if you have PMS-SUMATRIPTAN in your possession. Follow these steps:
- **Check Your Medication**: Review the packaging and your blister packs for any missing tablets. If empty blister packs are observed, discontinue use immediately.
- **Contact Your Pharmacist**: If you suspect your medication is part of the affected lot or notice any issues, return it to your pharmacy for a replacement or refund.
- **Consult with Your Doctor**: If you need assistance managing your migraines, speak with your healthcare provider for advice or alternative treatments.
- **Report Any Adverse Reactions**: Inform Health Canada of any health effects related to this product via their website or MedEffect service.
Prompt action can help minimize risks and ensure you have the proper medication to manage your migraines.
## Stay Safe – Get Instant Recall Alerts
Don’t let recalls catch you off-guard. Stay informed about product recalls like this one by signing up for Health Canada’s alert system or downloading our mobile app. With real-time updates, you’ll never miss an important safety notice.
### Download Our App for Free Today!
Be the first to know about critical product recalls by downloading our app now. Designed for busy individuals, our app provides instant alerts, safety tips, and actionable steps to help you stay ahead of any potential risks.
Product safety is a priority, and this recall highlights the importance of vigilance when it comes to medications. Always double-check your products, and remember to spread the word to friends and family who may also use PMS-SUMATRIPTAN. Safety starts with awareness.
For more details about this recall, visit the [official Health Canada recall notice](https://recalls-rappels.canada.ca/en/alert-recall/pms-sumatriptan-may-not-contain-correct-amount-tablets-empty-blister-packs). Stay safe and stay informed!